Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4642266
Max Phase: Preclinical
Molecular Formula: C30H37Cl2F3N6O4S
Molecular Weight: 632.71
Molecule Type: Unknown
Associated Items:
ID: ALA4642266
Max Phase: Preclinical
Molecular Formula: C30H37Cl2F3N6O4S
Molecular Weight: 632.71
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(-c2nc(NC(=O)c3cnc(N4CCC(C(=O)O)CC4)cn3)sc2CN2CCCC(C)(C)C2)cc1C(F)(F)F.Cl.Cl
Standard InChI: InChI=1S/C30H35F3N6O4S.2ClH/c1-29(2)9-4-10-38(17-29)16-23-25(19-5-6-22(43-3)20(13-19)30(31,32)33)36-28(44-23)37-26(40)21-14-35-24(15-34-21)39-11-7-18(8-12-39)27(41)42;;/h5-6,13-15,18H,4,7-12,16-17H2,1-3H3,(H,41,42)(H,36,37,40);2*1H
Standard InChI Key: HFROJXONFMIBGD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 632.71 | Molecular Weight (Monoisotopic): 632.2393 | AlogP: 5.80 | #Rotatable Bonds: 8 |
Polar Surface Area: 120.78 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.24 | CX Basic pKa: 8.18 | CX LogP: 2.82 | CX LogD: 2.77 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.32 | Np Likeness Score: -1.42 |
1. Tanaka H, Negoro K, Koike T, Tsukamoto I, Yokoyama K, Maeda J, Inagaki Y, Shimoshige Y, Ino K, Ishizu K, Takahashi T.. (2020) Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor., 28 (13): [PMID:32386953] [10.1016/j.bmc.2020.115531] |
Source(1):